BIOLASE (NASDAQ:BIOL) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of BIOLASE (NASDAQ:BIOL) in a report released on Tuesday. The firm set a “sell” rating on the medical technology company’s stock.

BIOLASE Stock Up 2.9 %

Shares of BIOLASE stock opened at $0.01 on Tuesday. The firm has a market cap of $410,906.10, a price-to-earnings ratio of 0.00 and a beta of 0.67. The business has a 50-day moving average price of $0.01 and a 200-day moving average price of $0.01. BIOLASE has a twelve month low of $0.02 and a twelve month high of $1.94.

BIOLASE Company Profile

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.